Document is current
Any future updates will be listed below
-
Authors
Phuntsog, Thupten D.
Stockman, Jamila K.
Amico, K. Rivet
Kofron, Ryan
Morris, Sheldon
Landovitz, Raphael J.
Strathdee, Steffanie
Moore, David J.
Blumenthal, Jill https://orcid.org/0000-0002-2307-9108
-
Funding
Funding for this research was provided by:
California HIV/AIDS Research Program (EI11-SD-005B)
California HIV/AIDS Research Program (E111-LA-002B)
Center for AIDS Research, University of California Los Angeles (5P30AI028697)
National Institutes of Health (TR001444)
- License Information
-
More Information
Article History
Accepted: 13 December 2025
First Online: 23 January 2026
Declarations
:
: Jill Blumenthal receives research funding and served on Scientific Advisory Boards for Gilead Sciences. Raphy Landovitz serves on Scientific Advisory Boards and Consultant to ViiV and Merck.
: The research protocol for this study was approved by the Institutional Review Boards at the University of California Los Angeles and the University of California San Diego. All participants provided written informed consents prior to participation. In addition, each participant was provided a Notice of Privacy Practices booklet and a Health Insurance Portability and Accountability Act (HIPAA) Authorization form.
: All participants provided written informed consents prior to participation. In addition, each participant was provided a Notice of Privacy Practices booklet and a Health Insurance Portability and Accountability Act (HIPAA) Authorization form.
